Amarin Corp. Plc (AMRN)

14.76 +0.67 (+4.76%) USD  |  NASDAQ  |  Feb 06, 16:00
14.78 +0.02 (+0.14%) After-Hours: 20:00
More

Amarin SG&A Expense (TTM) : 121.28M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for AMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Trinity Biotech Plc 31.76M
Jazz Pharmaceuticals Plc 1.772B
DBV Technologies SA 28.71M
Cellectis SA 19.93M
Akari Therapeutics Plc 10.20M